Controversial laser heart procedures find little favour among US MCAC (Medicare coverage advisory committee) panel
This article was originally published in Clinica
There is too little evidence to judge the potential health benefits of a procedure that uses lasers to drill holes in the heart's myocardium following coronary artery bypass surgery, a panel of experts told Medicare last week.
You may also be interested in...
More details about the controversial ORBITA trial.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.